Bioinformatics Tools (and Web Server) for Cancer Biomarker Development

125.3K
views
132
authors
17
articles
Cover image for research topic "Bioinformatics Tools (and Web Server) for Cancer Biomarker Development"
Editors
5
Impact
Loading...

Idiopathic pulmonary fibrosis (IPF) is a fibrotic interstitial lung disease with lesions confined to the lungs. To identify meaningful microRNA (miRNA) and gene modules related to the IPF progression, GSE32537 (RNA-sequencing data) and GSE32538 (miRNA-sequencing data) were downloaded and processed, and then weighted gene co-expression network analysis (WGCNA) was applied to construct gene co-expression networks and miRNA co-expression networks. GSE10667, GSE70866, and GSE27430 were used to make a reasonable validation for the results and evaluate the clinical significance of the genes and the miRNAs. Six hub genes (COL3A1, COL1A2, OGN, COL15A1, ASPN, and MXRA5) and seven hub miRNAs (hsa-let-7b-5p, hsa-miR-26a-5p, hsa-miR-25-3p, hsa-miR-29c-3p, hsa-let-7c-5p, hsa-miR-29b-3p, and hsa-miR-26b-5p) were clarified and validated. Meanwhile, iteration network of hub miRNAs-hub genes was constructed, and the emerging role of the network being involved in non-small cell lung cancer (NSCLC) was also analyzed by several webtools. The expression levels of hub genes were different between normal lung tissues and NSCLC tissues. Six genes (COL3A1, COL1A2, OGN, COL15A1, ASPN, and MXRA5) and three miRNAs (hsa-miR-29c-3p, hsa-let-7c-5p, and hsa-miR-29b-3p) were related to the survival time of lung adenocarcinoma (LUAD). The interaction network of hub miRNAs-hub genes might provide common mechanisms involving in IPF and NSCLC. More importantly, useful clues were provided for clinical treatment of both diseases based on novel molecular advances.

8,996 views
41 citations
Review
05 February 2020

Prognostic biomarkers are of great significance to predict the outcome of patients with cancer, to guide the clinical treatments, to elucidate tumorigenesis mechanisms, and offer the opportunity of identifying therapeutic targets. To screen and develop prognostic biomarkers, high throughput profiling methods including gene microarray and next-generation sequencing have been widely applied and shown great success. However, due to the lack of independent validation, only very few prognostic biomarkers have been applied for clinical practice. In order to cross-validate the reliability of potential prognostic biomarkers, some groups have collected the omics datasets (i.e., epigenetics/transcriptome/proteome) with relative follow-up data (such as OS/DSS/PFS) of clinical samples from different cohorts, and developed the easy-to-use online bioinformatics tools and web servers to assist the biomarker screening and validation. These tools and web servers provide great convenience for the development of prognostic biomarkers, for the study of molecular mechanisms of tumorigenesis and progression, and even for the discovery of important therapeutic targets. Aim to help researchers to get a quick learning and understand the function of these tools, the current review delves into the introduction of the usage, characteristics and algorithms of tools, and web servers, such as LOGpc, KM plotter, GEPIA, TCPA, OncoLnc, PrognoScan, MethSurv, SurvExpress, UALCAN, etc., and further help researchers to select more suitable tools for their own research. In addition, all the tools introduced in this review can be reached at http://bioinfo.henu.edu.cn/WebServiceList.html.

25,604 views
99 citations
Recommended Research Topics
Frontiers Logo

Frontiers in Oncology

Circulating Tumor DNA in Cancer: A Role as a Response and Monitoring “Next-Generation” Biomarker in Cancer therapy
Edited by Saeid Latifi-Navid, Reza Safaralizadeh, Lixuan Wei
71.2K
views
86
authors
11
articles
Frontiers Logo

Frontiers in Oncology

Advances in Genetics and Molecular Diagnosis in Colorectal, Stomach, and Pancreatic Cancer.
Edited by Carlos A Vaccaro, Mev Dominguez-Valentin, Walter Hernán Pavicic
31.4K
views
156
authors
11
articles
Frontiers Logo

Frontiers in Oncology

Strategic Molecular Biomarkers and MicroRNAs in Cancer
Edited by César López-Camarillo, Ondrej Slaby, Macrina Beatriz Silva Cázares
42.1K
views
70
authors
10
articles
Frontiers Logo

Frontiers in Oncology

New Therapeutic Approaches in Microsatellite Stable Colorectal Cancer Patients.
Edited by Alberto Puccini, Andreas Seeber
31.2K
views
70
authors
7
articles
Frontiers Logo

Frontiers in Oncology

Advances in Genetics and Molecular Diagnosis in Colorectal Cancer.
Edited by Jorge Melendez-Zajgla, Farhadul Islam
30.1K
views
92
authors
12
articles